Currently, nearly 10 million people across the United States and Europe find themselves confronting a high risk of developing liver cancer. This high risk demographic is largely composed of individuals suffering from cirrhosis, an insidious condition that can stem from multiple factors. Among these are obesity, which may progress to
The prognosis for liver cancer is significantly improved by early detection, which opens the door to curative treatments. These treatments range from local ablation, which destroys cancerous tissue, to surgical resection, where the diseased portion of the liver is removed. In more severe cases, a liver transplant may be the recommended course of action. With such high stakes, biannual screening through ultrasound is the standard recommendation for those at high risk. Nonetheless, this method's ability to detect liver cancer in its nascent stages is quite limited. The lack of sensitivity in ultrasound screenings means that early-stage tumours may go unnoticed, depriving patients of the opportunity for early intervention.
There is a pressing need for more effective diagnostic tools. Enhanced screening techniques could significantly improve early detection rates, thereby increasing the chances of successful treatment and survival for those affected by this condition.